Drugs & Targets FDA accepts Karyopharm’s sNDA for Xpovio as a treatment for multiple myeloma after at least one prior line of therapy July 24, 2020Vol.46 No.30
Drugs & Targets FDA issues draft guidance to encourage cannabis-related clinical research July 24, 2020Vol.46 No.30
Drugs & Targets FDA proposes rule on reporting requirement under Right to Try Act July 24, 2020Vol.46 No.30
Drugs & Targets Pfizer and BioNTech receive FDA Fast Track designation for investigational COVID-19 vaccine candidates July 17, 2020Vol.46 No.29
Drugs & Targets Ashion Analytics receives Medicare coverage for assay for advanced solid tumors July 17, 2020Vol.46 No.29
Drugs & Targets Keytruda’s sBLA receives Priority Review from FDA for second-line treatment of relapsed or refractory classical Hodgkin lymphoma July 10, 2020Vol.46 No.28
Drugs & Targets Lynparza approved in EU for germline BRCA-mutated metastatic pancreatic cancer July 10, 2020Vol.46 No.28
Drugs & Targets Phesgo receives FDA approval in breast cancer indication for at home treatment July 02, 2020Vol.46 No.27
